A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance
- Address correspondence and reprint requests to George Argyropoulos or Steve R. Smith, Pennington Biomedical Research Center, 6400 Perkins Rd., Baton Rouge, LA 70808. E-mail: argyrog{at}pbrc.edu or or smithsr{at}pbrc.edu
Abstract
Insulin resistance is a component of type 2 diabetes and often precedes pancreatic β-cell failure. Contributing factors include obesity and a central pattern of fat accumulation with a strong genetic component. The adipocyte secreted hormone resistin has been proposed as a link between the adipocyte and insulin resistance by inhibition of insulin-stimulated glucose uptake and/or blocking adipocyte differentiation. Here we report that the G/G genotype of a single nucleotide polymorphism (SNP) in the promoter of the human resistin gene, −180C>G, had significantly increased basal promoter activity in adipocytes. These data were recapitulated in vivo, where G/G homozygotes had significantly higher resistin mRNA levels in human abdominal subcutaneous fat. A significant interaction was also found between the −180C>G SNP, a marker of oxidative stress (NAD[P]H quinone oxidoreductase mRNA) and homeostasis model assessment of insulin resistance. In addition, resistin mRNA was positively and independently correlated with insulin resistance and hepatic fat as measured by liver X-ray attenuation. These data implicate resistin in the pathophysiology of the human insulin resistance syndrome, an effect mediated by the −180C>G promoter SNP and potentially cellular oxidative stress.
- CT, computed tomography
- DEXA, dual X-ray absorptiometry
- HOMA-IR, homeostasis model assessment of insulin resistance
- NQO, NAD(P)H:quinone oxidoreductase
- PPAR, peroxisome proliferator–activated receptor
- SNP, single nucleotide polymorphism
- TZD, thiazolidinedione
Footnotes
-
- Accepted March 19, 2003.
- Received December 4, 2002.
- DIABETES














